Emergent BioSolutions wins $52.7M U.S. government smallpox vaccine deal

Go back to Emergent BioSolutions wins $52.7M U.S. government smallpox vaccine deal
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 7.26 -0.24 (3.2%)
Previous Close $7.50    52 Week High $44.38 
Open $7.51    52 Week Low $24.47 
Day High $7.65    P/E 363.00 
Day Low $7.24    EPS $0.02 
Volume 553,904